Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis.
Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis. Mult Scler. 2021 12; 27(14):2170-2179.
View in:
PubMed
subject areas
CD8-Positive T-Lymphocytes
Humans
Leukocytes, Mononuclear
Multiple Sclerosis
T-Lymphocyte Subsets
T-Lymphocytes, Regulatory
authors with profiles
Anthony T. Reder